Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Unknown 2Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Gastrointestinal 1

Conditions

Multiple Myeloma 1Carcinoma, Hepatocellular 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × darinaparsin × Clear all
NCT00423306 2013-11-14

A Phase-II Trial of ZIO 101 in Advanced Hepatocellular Carcinoma

Alaunos Therapeutics

Phase 2 Unknown
15 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00423644 2013-11-14

A Phase II Trial of ZIO-101 in Advanced Multiple Myeloma: Protocol SGL2001b

Alaunos Therapeutics

Phase 2 Unknown
17 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡